Why these 4 ASX shares have started the week deep in the red

The Domino's Pizza Enterprises Ltd. (ASX:DMP) share price is one of four starting the week deep in the red. Here's what you need to know…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has had a disappointing start to the week. In early afternoon trade the index is down 0.4% to 5,725 points.

Four shares which have started the week with even greater declines are listed below. Here's why they have started the week deep in the red:

The Apiam Animal Health Ltd (ASX: AHX) share price has tumbled 14% to 68 cents. The veterinary products and services provider's shares fell over 30% on Friday following the release of its full-year guidance. Increases in its cost base and falling margins appear to have concerned some investors.

The Domino's Pizza Enterprises Ltd. (ASX: DMP) share price has fallen 4% to $59.14. Today's decline appears to relate to a research note out of Morgans which revealed that its analysts have downgraded the pizza chain operator to a hold rating with a $65.62 price target. I believe this latest decline puts Domino's at an appealing level for a buy and hold investment.

The DWS Ltd (ASX: DWS) share price has dropped almost 9% to $1.68 after it emerged that fellow IT services company ASG Group had made a move for SMS Management & Technology Limited (ASX: SMX). DWS had hoped to acquire SMS Management & Technology for the equivalent of $1.61 per share. ASG Group has made a non-binding expression of interest valuing SMS at $1.80 in cash per share.

The Zelda Therapeutics Ltd (ASX: ZLD) share price has plunged 11% to 6.6 cents. Today's decline means the pot stock has fallen over 37% this month despite there not being a single piece of news out of the company. As I said earlier, unfortunately this decline is an example of why investing in the medicinal cannabis industry is not suitable for the majority of investors.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »